Target intelligence / Profile preview

Collagen synthesis upregulation

Molecular classification
Other (biological process, not a single molecule)
01

Overview

Collagen synthesis upregulation" refers to the biological process in which the production of collagen proteins is increased, usually through enhanced transcription, translation, or post-translational modification of collagen genes. Collagen, the most abundant structural protein in mammals, plays a central role in tissue strength, extracellular matrix composition, and overall connective tissue function. This synthesis is tightly regulated at multiple levels, involving transcription of COL genes, translation of propeptide chains, and extensive post-translational modifications such as hydroxylation, glycosylation, triple-helix formation, and extracellular assembly into fibrils[1][2][3][4][5][6][7]. Upregulation can be physiological (wound healing, tissue remodeling) or pathological (fibrosis, scar formation, organ dysfunction).

Other names
Collagen productionincreased collagen synthesisenhanced collagen biosynthesiscollagen upregulation
02

Mechanism of action

Enzyme cofactor (ascorbic acid/vitamin C is essential for prolyl and lysyl hydroxylase activity); Inhibition of growth factors (e.g., TGF-beta inhibition reduces fibrotic collagen production); Anti-fibrotic (inhibition of key steps in pathological collagen synthesis/secretion)

03

Biological functions

Extracellular matrix formationTissue repair and remodelingCell adhesionWound healingFibrosis
04

Disease associations

Fibrotic diseases (lung fibrosis, liver fibrosis, systemic sclerosis)Aging (skin aging, pulmonary aging)Connective tissue disorders (Ehlers-Danlos syndrome, osteogenesis imperfecta)Wound healing/RepairOther
05

Safety considerations

Aberrant upregulation leads to tissue fibrosis and organ dysfunctionInhibition may impair normal tissue repair and wound healingVitamin C deficiency impairs collagen biosynthesis, leading to scurvy
06

Interacting drugs

Indirect: Vitamin C (ascorbic acid), which is required for collagen hydroxylase enzymes

2 more in the full profile.

07

Biomarkers

Procollagen type I N-terminal propeptide (PINP)Procollagen type III N-terminal propeptide (PIIINP)Hydroxyproline (a marker of collagen turnover)

Beyond the preview

Go deeper on Collagen synthesis upregulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen synthesis upregulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call